Gilead Sciences
GILD
#105
Rank
HK$1.376 T
Marketcap
HK$1,109
Share price
1.72%
Change (1 day)
48.88%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): HK$50.82

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is HK$50.94. In 2024 the company made an earnings per share (EPS) of HK$2.97 a decrease over its 2023 EPS that were of HK$35.55.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$50.821611.65%
2024HK$2.97-91.65%
2023HK$35.5523.98%
2022HK$28.67-25.86%
2021HK$38.674850%
2020HK$0.78-97.64%
2019HK$33.130.9%
2018HK$32.8318.71%
2017HK$27.66-64.88%
2016HK$78.75-18.45%
2015HK$96.5655.28%
2014HK$62.19296.02%
2013HK$15.7017.89%
2012HK$13.32

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.56 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.44-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.56-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$160.30 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.80 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$85.86 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$34.92-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$111.96 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$59.33 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA